Grant: Alliance Grants
Queen's University
$30,000.00
Development of total consumption systems for inductively coupled plasma mass spectrometry in single particle and single cell modes
FY 2022-23
Summary
Metal nanoparticles are increasingly used in cosmetics, food packaging, textiles, toothpaste, and other ubiquitous products. These nanoparticles may end up in the potable water of rural and indigenous communities without water treatment plants, putting these populations at risk. The impact of these nanoparticles on our environment, our food, and our health is largely unknown because measuring nanoparticles in environmental and biological systems is very difficult. Similarly, measuring the uptake of metal-containing drugs by cells to develop smart therapeutics targeting tumors is also difficult because it requires analysis of numerous individual cells to assess the selectivity of the drug uptake by diseased cells versus healthy cells. This partnership aims to develop sample introduction systems (one for the analysis of nanoparticles, one for the analysis of cells) allowing the quick analysis of every nanoparticle or cell in each sample, which is not currently possible, to provide a complete picture. The systems to be developed are expected to facilitate the analysis of real samples, such as natural waters and other environmental samples by reducing or eliminating the sample pretreatment that is currently required with standard sample introduction systems, thereby increasing the number of samples that can be analyzed daily. The system that will be optimized for the analysis of cells will be used to assess the efficiency and selectivity of new drugs being designed by collaborators. Such analysis will allow drug dosage to be adjusted so that cancerous cells are preferentially targeted. It would in turn allow the advancement of copper- and nickel-containing targeted therapeutics to treat cancer and neurological disorders. A switch from platinum (currently used in anti-cancer drugs) to copper or nickel in therapeutic candidates would greatly benefit patients' access to more affordable (hence equitable) and safer medication. The intention is to patent the resulting systems and allow Burgener Research, a Canadian manufacturer of sample introduction systems, to sell them. Canada would then become a world leader in the measurement of nanoparticles and cells.
Program
Alliance Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
578516-2022
Name nom
Beauchemin, Diane D
Department département
Chemistry
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
30000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
515
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Instrumentation technology
Area of application fr
Technologie de l'instrumentation
Research subject code
3505
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical spectroscopy
Research subject fr
Spectroscopie analytique
Installment
inst:1
Partie
1
Nb partie
1
Application title
Development of total consumption systems for inductively coupled plasma mass spectrometry in single particle and single cell modes
Application summary
Metal nanoparticles are increasingly used in cosmetics, food packaging, textiles, toothpaste, and other ubiquitous products. These nanoparticles may end up in the potable water of rural and indigenous communities without water treatment plants, putting these populations at risk. The impact of these nanoparticles on our environment, our food, and our health is largely unknown because measuring nanoparticles in environmental and biological systems is very difficult. Similarly, measuring the uptake of metal-containing drugs by cells to develop smart therapeutics targeting tumors is also difficult because it requires analysis of numerous individual cells to assess the selectivity of the drug uptake by diseased cells versus healthy cells. This partnership aims to develop sample introduction systems (one for the analysis of nanoparticles, one for the analysis of cells) allowing the quick analysis of every nanoparticle or cell in each sample, which is not currently possible, to provide a complete picture. The systems to be developed are expected to facilitate the analysis of real samples, such as natural waters and other environmental samples by reducing or eliminating the sample pretreatment that is currently required with standard sample introduction systems, thereby increasing the number of samples that can be analyzed daily. The system that will be optimized for the analysis of cells will be used to assess the efficiency and selectivity of new drugs being designed by collaborators. Such analysis will allow drug dosage to be adjusted so that cancerous cells are preferentially targeted. It would in turn allow the advancement of copper- and nickel-containing targeted therapeutics to treat cancer and neurological disorders. A switch from platinum (currently used in anti-cancer drugs) to copper or nickel in therapeutic candidates would greatly benefit patients' access to more affordable (hence equitable) and safer medication. The intention is to patent the resulting systems and allow Burgener Research, a Canadian manufacturer of sample introduction systems, to sell them. Canada would then become a world leader in the measurement of nanoparticles and cells.